Serveur d'exploration Covid (26 mars) - Analysis (new)

Index « AbsEn.i » - entrée « drug »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
droplets < drug < druggable  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000067 (2020) Haiou Li [République populaire de Chine] ; Yunjiao Zhou [République populaire de Chine] ; Meng Zhang [République populaire de Chine] ; Haizhou Wang [République populaire de Chine] ; Qiu Zhao [République populaire de Chine] ; Jing Liu [République populaire de Chine]Updated approaches against SARS-CoV-2.
000074 (2020) Andre C. Kalil [États-Unis]Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.
000092 (2020) Robert L. Kruse [États-Unis]Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.
000115 (2020) Jin-Yan Li [République populaire de Chine] ; Zhi You [République populaire de Chine] ; Qiong Wang [République populaire de Chine] ; Zhi-Jian Zhou [République populaire de Chine] ; Ye Qiu [République populaire de Chine] ; Rui Luo [République populaire de Chine] ; Xing-Yi Ge [République populaire de Chine]The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.
000139 (2020) Sophie Alexandra Baron [France] ; Christian Devaux [France] ; Philippe Colson [France] ; Didier Raoult [France] ; Jean-Marc Rolain [France]Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19?
000206 (2020) Ken J. Goh [Singapour] ; Mindy Cm Choong ; Elizabeth Ht Cheong ; Shirin Kalimuddin ; Sewa Duu Wen ; Ghee Chee Phua ; Kian Sing Chan ; Salahudeen Haja MohideenRapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from COVID-19 Infection.
000278 (2020) Yadi Zhou [États-Unis] ; Yuan Hou [États-Unis] ; Jiayu Shen [États-Unis] ; Yin Huang [États-Unis] ; William Martin [États-Unis] ; Feixiong Cheng [États-Unis]Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
000286 (2020) Garret A. Fitzgerald [États-Unis]Misguided drug advice for COVID-19.
000304 (2020) Ali Rismanbaf [Iran] ; Sara Zarei [Iran]Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor
000312 (2020) Jared S. Morse [États-Unis] ; Tyler Lalonde [États-Unis] ; Shiqing Xu [États-Unis] ; Wenshe Ray Liu [États-Unis]Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.
000353 (2020) Ling Lin [République populaire de Chine] ; Lianfeng Lu [République populaire de Chine] ; Wei Cao [République populaire de Chine] ; Taisheng Li [République populaire de Chine]Hypothesis for potential pathogenesis of SARS-CoV-2 infection--a review of immune changes in patients with viral pneumonia.
000365 (2020) David S. Fedson [Oman] ; Steven M. Opal [États-Unis] ; Ole Martin Rordam [Norvège]Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection.
000372 (2020) Anup Agarwal [Inde] ; Nazia Nagi [Inde] ; Pranab Chatterjee [Inde] ; Swarup Sarkar [Inde] ; Devendra Mourya [Inde] ; Rima Rakeshkumar Sahay [Inde] ; Rajesh Bhatia [Inde]Guidance for building a dedicated health facility to contain the spread of the 2019 novel coronavirus outbreak.
000427 (2020) Hongzhou Lu [République populaire de Chine]Drug treatment options for the 2019-new coronavirus (2019-nCoV).
000428 (2020) Manisha Prajapat ; Phulen Sarma ; Nishant Shekhar ; Pramod Avti ; Shweta Sinha ; Hardeep Kaur ; Subodh Kumar ; Anusuya Bhattacharyya ; Harish Kumar ; Seema Bansal ; Bikash MedhiDrug targets for corona virus: A systematic review
000442 (2020) Linlin Zhang [Allemagne] ; Daizong Lin [Allemagne] ; Xinyuanyuan Sun [Allemagne] ; Ute Curth [Allemagne] ; Christian Drosten [Allemagne] ; Lucie Sauerhering [Allemagne] ; Stephan Becker [Allemagne] ; Katharina Rox [Allemagne] ; Rolf Hilgenfeld [Allemagne]Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
000463 (2020) Janice Hopkins Tanne [États-Unis]Covid-19: cases grow in US as Trump pushes promise of a malaria drug.
000687 (2019) Ya Zhao [République populaire de Chine] ; Limin Feng [République populaire de Chine] ; Lijuan Liu [République populaire de Chine] ; Ruizhi Zhao [République populaire de Chine]Saikosaponin b2 enhances the hepatotargeting effect of anticancer drugs through inhibition of multidrug resistance-associated drug transporters
000690 (2019) Lan Li ; Xiaoming Yu ; Haoming Zhang ; Haiwei Cheng ; Liting Hou ; Qisheng Zheng ; Jibo HouIn vitro antiviral activity of Griffithsin against porcine epidemic diarrhea virus
000691 (2019) Sima Khajouei ; Hadi Ravan ; Ali EbrahimiDNA hydrogel-empowered biosensing
000739 (2014) Hussain Badani [États-Unis] ; Robert F. Garry [États-Unis] ; William C. Wimley [États-Unis]Peptide entry inhibitors of enveloped viruses: The importance of interfacial hydrophobicity☆

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/new/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/AbsEn.i -k "drug" 
HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/AbsEn.i  \
                -Sk "drug" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/new/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    new
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    drug
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021